by Mooslet Writing Services | Jun 30, 2016 | Uncategorized
The rise and fall of Valeant Pharmaceuticals may be a teachable moment for the entire pharma industry: gouge the public at your peril. On July 31, 2015, the Canadian company seemed like a pharma dream come true. On that date, Valeant’s stock price hit an all-time high...
by Mooslet Writing Services | Jun 28, 2016 | Big Pharma Lawsuits
West Virginia state agencies have settled half their lawsuits against drug wholesalers accused of illegally supplying opioids. So far, the settlements have totaled $6.7 million from six different pharmaceutical distributors: Miami-Luken – $2.5 million Anda...
by Mooslet Writing Services | Jun 27, 2016 | Prescription Drugs
Lawmakers from both houses on Capitol Hill are taking aim at obstructionary practices used by brand-name pharmaceutical companies against would-be makers of generic drugs. In the Senate, a bipartisan group comprised of members from the Judiciary Committee and its...
by Mooslet Writing Services | Jun 23, 2016 | Clinical Trials
What is the value of being able to see? If it costs a half a million dollars per eye to cure genetic blindness, would you do it? Now, let’s make the scenario more complex. Let’s say a cure for hemophilia B would run you $4 million upfront. Would you instead agree to...
by Mooslet Writing Services | Jun 21, 2016 | Consumer Healthcare
The World Health Organization (WHO) recently announced that fears about the mosquito-borne Zika virus should not halt the Olympic Games in Rio de Janeiro, Brazil. The global health organization said that athletes and visitors should go forward with their travel plans....
by Mooslet Writing Services | Jun 20, 2016 | Prescription Drugs
First, it was propofol, the drug that killed Michael Jackson. Then came fentanyl, which killed pop icon Prince. If the pharmaceutical industry has its way, deaths from prescription drugs like these are not likely to decrease anytime soon. The latest pharma scandal to...
by Mooslet Writing Services | Jun 16, 2016 | Big Pharma Lawsuits
A recent battle of pharmaceutical heavyweights Gilead and Merck has resulted in both companies walking away with a black eye. The dispute over a hepatitis C drug patent showed Gilead as the clear loser but also denied Merck its $200 million winning settlement....
by Mooslet Writing Services | Jun 14, 2016 | Uncategorized
Delaware state health officials have agreed to change the state’s Medicaid guidelines to make it easier for patients to get Hepatitis C medicine. The move comes as a result of a demand letter sent to Delaware state officials by the Center for Health Law and Policy...
by Mooslet Writing Services | Jun 13, 2016 | Big Pharma Lawsuits
The US Department of Justice (DOJ) recently announced that it had reached a $67 million settlement with two pharmaceutical companies over alleged false claims made about cancer drug Tarceva. Pharma Companies Misled Doctors for Six Years The lawsuit was brought about...
by Mooslet Writing Services | Jun 9, 2016 | Big Pharma Business
There’s a new face in the crowded pharmaceutical marketplace – Samsung. The mobile technology juggernaut responsible for Galaxy smartphones is diversifying into the lucrative biosimilar pharmaceutical business. Samsung already makes medical devices like...
Recent Comments